200 related articles for article (PubMed ID: 37697350)
1. Translocator protein (18kDA) (TSPO) marks mesenchymal glioblastoma cell populations characterized by elevated numbers of tumor-associated macrophages.
Weidner L; Lorenz J; Quach S; Braun FK; Rothhammer-Hampl T; Ammer LM; Vollmann-Zwerenz A; Bartos LM; Dekorsy FJ; Holzgreve A; Kirchleitner SV; Thon N; Greve T; Ruf V; Herms J; Bader S; Milenkovic VM; von Baumgarten L; Menevse AN; Hussein A; Sax J; Wetzel CH; Rupprecht R; Proescholdt M; Schmidt NO; Beckhove P; Hau P; Tonn JC; Bartenstein P; Brendel M; Albert NL; Riemenschneider MJ
Acta Neuropathol Commun; 2023 Sep; 11(1):147. PubMed ID: 37697350
[TBL] [Abstract][Full Text] [Related]
2. Glioblastoma Exhibits Inter-Individual Heterogeneity of TSPO and LAT1 Expression in Neoplastic and Parenchymal Cells.
Cai L; Kirchleitner SV; Zhao D; Li M; Tonn JC; Glass R; Kälin RE
Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31963507
[TBL] [Abstract][Full Text] [Related]
3. TSPO PET signal using [
Quach S; Holzgreve A; Kaiser L; Unterrainer M; Dekorsy FJ; Nelwan DV; Bartos LM; Kirchleitner SV; Weller J; Weidner L; Niyazi M; Ruf VC; Herms J; Stöcklein S; Wetzel C; Riemenschneider MJ; V Baumgarten L; Thon N; Brendel M; Rupprecht R; Bartenstein P; Tonn JC; Albert NL
Eur J Nucl Med Mol Imaging; 2023 Feb; 50(3):859-869. PubMed ID: 36329288
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Value of TSPO PET Before Radiotherapy in Newly Diagnosed IDH-Wild-Type Glioblastoma.
Albert NL; Nelwan DV; Fleischmann DF; Quach S; von Rohr K; Kaiser L; Teske N; Unterrainer LM; Bartos LM; Ruf VC; Brendel M; Riemenschneider MJ; Wetzel C; Herms J; Rupprecht R; Thon N; Tonn JC; Belka C; Bartenstein P; von Baumgarten L; Niyazi M; Unterrainer M; Holzgreve A
J Nucl Med; 2023 Oct; 64(10):1519-1525. PubMed ID: 37536737
[TBL] [Abstract][Full Text] [Related]
5. TSPO PET, tumour grading and molecular genetics in histologically verified glioma: a correlative
Unterrainer M; Fleischmann DF; Vettermann F; Ruf V; Kaiser L; Nelwan D; Lindner S; Brendel M; Wenter V; Stöcklein S; Herms J; Milenkovic VM; Rupprecht R; Tonn JC; Belka C; Bartenstein P; Niyazi M; Albert NL
Eur J Nucl Med Mol Imaging; 2020 Jun; 47(6):1368-1380. PubMed ID: 31486876
[TBL] [Abstract][Full Text] [Related]
6. Deciphering sources of PET signals in the tumor microenvironment of glioblastoma at cellular resolution.
Bartos LM; Kirchleitner SV; Kolabas ZI; Quach S; Beck A; Lorenz J; Blobner J; Mueller SA; Ulukaya S; Hoeher L; Horvath I; Wind-Mark K; Holzgreve A; Ruf VC; Gold L; Kunze LH; Kunte ST; Beumers P; Park HE; Antons M; Zatcepin A; Briel N; Hoermann L; Schaefer R; Messerer D; Bartenstein P; Riemenschneider MJ; Lindner S; Ziegler S; Herms J; Lichtenthaler SF; Ertürk A; Tonn JC; von Baumgarten L; Albert NL; Brendel M
Sci Adv; 2023 Oct; 9(43):eadi8986. PubMed ID: 37889970
[TBL] [Abstract][Full Text] [Related]
7. Pro-inflammatory activation of primary microglia and macrophages increases 18 kDa translocator protein expression in rodents but not humans.
Owen DR; Narayan N; Wells L; Healy L; Smyth E; Rabiner EA; Galloway D; Williams JB; Lehr J; Mandhair H; Peferoen LA; Taylor PC; Amor S; Antel JP; Matthews PM; Moore CS
J Cereb Blood Flow Metab; 2017 Aug; 37(8):2679-2690. PubMed ID: 28530125
[TBL] [Abstract][Full Text] [Related]
8. Imaging of the glioma microenvironment by TSPO PET.
Zinnhardt B; Roncaroli F; Foray C; Agushi E; Osrah B; Hugon G; Jacobs AH; Winkeler A
Eur J Nucl Med Mol Imaging; 2021 Dec; 49(1):174-185. PubMed ID: 33721063
[TBL] [Abstract][Full Text] [Related]
9. TSPO PET for glioma imaging using the novel ligand
Albert NL; Unterrainer M; Fleischmann DF; Lindner S; Vettermann F; Brunegraf A; Vomacka L; Brendel M; Wenter V; Wetzel C; Rupprecht R; Tonn JC; Belka C; Bartenstein P; Niyazi M
Eur J Nucl Med Mol Imaging; 2017 Dec; 44(13):2230-2238. PubMed ID: 28821920
[TBL] [Abstract][Full Text] [Related]
10. A quantitative neuropathological assessment of translocator protein expression in multiple sclerosis.
Nutma E; Stephenson JA; Gorter RP; de Bruin J; Boucherie DM; Donat CK; Breur M; van der Valk P; Matthews PM; Owen DR; Amor S
Brain; 2019 Nov; 142(11):3440-3455. PubMed ID: 31578541
[TBL] [Abstract][Full Text] [Related]
11. Activated microglia do not increase 18 kDa translocator protein (TSPO) expression in the multiple sclerosis brain.
Nutma E; Gebro E; Marzin MC; van der Valk P; Matthews PM; Owen DR; Amor S
Glia; 2021 Oct; 69(10):2447-2458. PubMed ID: 34145928
[TBL] [Abstract][Full Text] [Related]
12. The translocator protein ligand [¹⁸F]DPA-714 images glioma and activated microglia in vivo.
Winkeler A; Boisgard R; Awde AR; Dubois A; Thézé B; Zheng J; Ciobanu L; Dollé F; Viel T; Jacobs AH; Tavitian B
Eur J Nucl Med Mol Imaging; 2012 May; 39(5):811-23. PubMed ID: 22270507
[TBL] [Abstract][Full Text] [Related]
13. Preclinical TSPO Ligand PET to Visualize Human Glioma Xenotransplants: A Preliminary Study.
Buck JR; McKinley ET; Fu A; Abel TW; Thompson RC; Chambless L; Watchmaker JM; Harty JP; Cooper MK; Manning HC
PLoS One; 2015; 10(10):e0141659. PubMed ID: 26517124
[TBL] [Abstract][Full Text] [Related]
14. Quantitative, preclinical PET of translocator protein expression in glioma using 18F-N-fluoroacetyl-N-(2,5-dimethoxybenzyl)-2-phenoxyaniline.
Buck JR; McKinley ET; Hight MR; Fu A; Tang D; Smith RA; Tantawy MN; Peterson TE; Colvin D; Ansari MS; Baldwin RM; Zhao P; Guleryuz S; Manning HC
J Nucl Med; 2011 Jan; 52(1):107-14. PubMed ID: 21149488
[TBL] [Abstract][Full Text] [Related]
15. Translocator protein (TSPO) expression in neoplastic cells and tumor-associated macrophages in meningiomas.
Blum N; Mirian C; Maier AD; Mathiesen TI; Vilhardt F; Haslund-Vinding JL
J Neuropathol Exp Neurol; 2023 Nov; 82(12):1020-1032. PubMed ID: 37952221
[TBL] [Abstract][Full Text] [Related]
16. TSPO imaging-guided characterization of the immunosuppressive myeloid tumor microenvironment in patients with malignant glioma.
Zinnhardt B; Müther M; Roll W; Backhaus P; Jeibmann A; Foray C; Barca C; Döring C; Tavitian B; Dollé F; Weckesser M; Winkeler A; Hermann S; Wagner S; Wiendl H; Stummer W; Jacobs AH; Schäfers M; Grauer OM
Neuro Oncol; 2020 Jul; 22(7):1030-1043. PubMed ID: 32047908
[TBL] [Abstract][Full Text] [Related]
17. Resolving the cellular specificity of TSPO imaging in a rat model of peripherally-induced neuroinflammation.
Vicente-Rodríguez M; Singh N; Turkheimer F; Peris-Yague A; Randall K; Veronese M; Simmons C; Karim Haji-Dheere A; Bordoloi J; Sander K; Awais RO; Årstad E; Nima Consortium ; Cash D; Parker CA
Brain Behav Immun; 2021 Aug; 96():154-167. PubMed ID: 34052363
[TBL] [Abstract][Full Text] [Related]
18. A map of the spatial distribution and tumour-associated macrophage states in glioblastoma and grade 4 IDH-mutant astrocytoma.
Yin W; Ping YF; Li F; Lv SQ; Zhang XN; Li XG; Guo Y; Liu Q; Li TR; Yang LQ; Yang KD; Liu YQ; Luo CH; Luo T; Wang WY; Mao M; Luo M; He ZC; Cao MF; Chen C; Miao JY; Zeng H; Wang C; Zhou L; Yang Y; Yang X; Wang QH; Feng H; Shi Y; Bian XW
J Pathol; 2022 Oct; 258(2):121-135. PubMed ID: 35723032
[TBL] [Abstract][Full Text] [Related]
19. TSPO-PET and diffusion-weighted MRI for imaging a mouse model of infiltrative human glioma.
Pigeon H; Pérès EA; Truillet C; Jego B; Boumezbeur F; Caillé F; Zinnhardt B; Jacobs AH; Le Bihan D; Winkeler A
Neuro Oncol; 2019 Jun; 21(6):755-764. PubMed ID: 30721979
[TBL] [Abstract][Full Text] [Related]
20. Comparison of
Unterrainer M; Fleischmann DF; Diekmann C; Vomacka L; Lindner S; Vettermann F; Brendel M; Wenter V; Ertl-Wagner B; Herms J; Wetzel C; Rupprecht R; Tonn JC; Belka C; Bartenstein P; Niyazi M; Albert NL
Eur J Nucl Med Mol Imaging; 2019 Mar; 46(3):580-590. PubMed ID: 30244386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
